CPT only copyright 2011 American Medical Association. Page 2 of 5 What You Need to Know This article explains the difference between a National Provider Identifier (NPI) and a Provider Transaction Access Number (PTAN). There are no policy changes in this article.
For people with aggressive B cell non-Hodgkin lymphoma, we commonly recommend a chemotherapy treatment called R-CHOP. It is named after the medicines included in the mixture: rituximab (RituxanÂ®), a monoclonal antibody that helps your immune system destroy the cancer cells and makes the chemotherapy more powerful
Hodgkin's Lymphoma vs. Non-Hodgkin's Lymphoma. Hodgkinâs and non-Hodgkin lymphoma are types of blood cancer that originate in lymphocytes, or white blood cells. A vast majority (90%) of lymphomas are non-Hodgkin. Hodgkin's disease was the first form of lymphoma described and defined in 1832.